All stock lists
XBiotech Inc. (NASDAQ:XBIT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.94-0.05 (-2.51%)
Market cap
$59.1M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 15, 2015
Website
Insider Score
/ 99
XBIT Insider Score
XBiotech Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Unlock XBIT’s Insider ScoreFinancial Health Score
Sound
From XBIT’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$45.1M
- Net margin
- —
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $109.5M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $111.2M
- Current liabilities
- $3.4M
- Current ratio
- 33.15
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$40.7M
- Free cash flow
- -$40.8M
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 30.5M
- Share growth (1y)
- 0.0%
- Cash runway
- 32 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
XBIT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 332.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -332.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 850.00 K | 1.07 M | 4.40 M | 967.00 K | 1.00 M | 1.93 M |
| R&D Expense | 5.30 M | 5.21 M | 25.36 M | 5.08 M | 5.34 M | 11.62 M |
| Operating Expenses | 6.15 M | 5.94 M | 29.75 M | 6.05 M | 6.34 M | 13.55 M |
| Operating Income | -6.15 M | -6.27 M | -29.75 M | -6.05 M | -6.34 M | -13.55 M |
| Pretax Income | -6.68 M | -5.46 M | -26.82 M | -5.91 M | -1.73 M | -10.86 M |
| Tax Provision | 46.00 K | 49.00 K | 76.00 K | 102.00 K | 28.00 K | 29.00 K |
| Net Income | -6.73 M | -5.50 M | -26.89 M | -6.01 M | -1.76 M | -10.88 M |
| EPS (Basic) | -0.22 | -0.18 | -0.88 | -0.20 | -0.06 | -0.36 |
| EPS (Diluted) | -0.22 | -0.18 | -0.88 | -0.20 | -0.06 | -0.36 |
| Shares Outstanding | 30.49 M | 30.49 M | 30.49 M | 30.49 M | 30.49 M | 30.49 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.